Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016

References

• US Public Health Service. ALS Registry Act. Washington, DC: 110th Congress 2008.
   Google Scholar
• Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Available at: https://www.cdc.gov/nndss/infectious-tables.html. Atlanta, GA [Available from: https://www.cdc.gov/nndss/infectious-tables.html.
   Google Scholar
• Centers for Disease Control and Prevention. 2021 National Notifiable Infectious Diseases. Available at https://wwwn.cdc.gov/nndss/conditions/notifiable/2021/infectious-diseases/.
   Google Scholar
• Massachusetts Department of Public Health. Massachusetts ALS Registry. Available at: https://www.mass.gov/als-registry. [Available from: https://www.mass.gov/als-registry.
   Google Scholar
• Insurance Information Institute. Facts + Statistics: Industry Overview. Available at: https://www.iii.org/fact-statistic/facts-statistics-industry-overview. [Available from: https://www.iii.org/fact-statistic/facts-statistics-industry-overview.
   Google Scholar
• Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:433–9.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National ALS Registry. Available at: https://www.cdc.gov/als/.
   Google Scholar
• Centers for Disease Control and Prevention. National Death Index. Available at: https://www.cdc.gov/nchs/ndi/index.htm
   Google Scholar
• Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Centers for Disease Control and Prevention (CDC), et al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR Suppl. 2014;63:1–14.
   PubMedGoogle Scholar
• Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2012-2013. MMWR Surveill Summ. 2016;65:1–12.
   PubMed Web of Science ®Google Scholar
• Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285–9.
   PubMed Web of Science ®Google Scholar
• Mehta P, Kaye W, Raymond J, Wu R, Larson T, Punjani R, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67:216–8.
   PubMed Web of Science ®Google Scholar
• Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001 Jan;(20):1–10.
   PubMedGoogle Scholar
• U.S. Census Bureau. ACS Demographic and Housing Estimates. Available at: https://data.census.gov/cedsci/table?d=ACS%205-Year%20Estimates%20Data%20Profiles&tid=ACSDP5Y2016.DP05
   Google Scholar
• Keyfitz N. 3. Sampling variance of standardized mortality rates. Hum Biol. 1966;38:309–17.
   PubMed Web of Science ®Google Scholar
• Horton DK, Mehta P, Antao VC. Quantifying a nonnotifiable disease in the United States: the National amyotrophic lateral sclerosis registry model. JAMA 2014;312:1097–8.
   PubMed Web of Science ®Google Scholar
• Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T. Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:303–10.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Gibson HN, Gatrell A. Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986: a geographical study. Arch Neurol. 1990;47:875–80.
   PubMedGoogle Scholar
• Huber S, Henn V. Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zürich. Schweiz Arch Neurol Psychiatr (1985) 1995;146:52–4.
   PubMedGoogle Scholar
• Bettoni L, Bazzani M, Bortone E, Dascola I, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960-1990. Acta Neurol Scand. 2009;90:276–80.
   Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Dupré N, Korngut L. A real-world glimpse into the epidemiology of ALS in Canada. Can J Neurol Sci. 2013;40:625.
   PubMed Web of Science ®Google Scholar
• US Census Bureau. Total population 2014 American community survey 1-year. Washington, DC: US Department of Commerce, US Census Bureau; 2014. Available at: https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2014/
   Google Scholar
• Larson TC, Kaye W, Mehta P, Horton DK. Amyotrophic lateral sclerosis mortality in the United States, 2011-2014. Neuroepidemiology 2018;51:96–103.
   PubMed Web of Science ®Google Scholar
• Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology 2005;64:1215–21.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services. What is Medicare Part C?Available at: https://www.hhs.gov/answers/medicare-and-medicaid/what-is-medicare-part-c/index.html.
   Google Scholar
• Irish Motor Neurone Disease Register. Available at: https://www.hiqa.ie/areas-we-work/health-information/data-collections/irish-motor-neurone-disease-register. [Available from: https://www.hiqa.ie/areas-we-work/health-information/data-collections/irish-motor-neurone-disease-register.
   Google Scholar
• Chiò A, Cucatto A, Calvo A, Terreni AA, Magnani C, Schiffer D. Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. J Neurol. 1999;246:175–80.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Wittes JT, Colton T, Sidel VW. Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. J Chronic Dis. 1974;27:25–36.
   PubMedGoogle Scholar
• Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135:1060–7.
   PubMed Web of Science ®Google Scholar